Precise Investors

Monday, September 26, 2022
Stocks & Shares

London stocks set to gain, Brexit talks in focus


Discussions between the UK and the EU are due to resume amid reports the UK government is planning new legislation that would partially undermine the EU withdrawal agreement

London stocks were set to gain at the open on Monday following losses at the end of last week, as investors mulled over the latest Chinese trade figures.

The FTSE 100 was called to open 46 points higher at 5,845.

CMC Markets analyst David Madden said: Overnight, China posted its trade data for August. The export metric was 9.5%, while economists were expecting 7.1%, and the previous reading was 7.2%. Imports fell by 2.1%, and the consensus estimate was for growth of 0.1%. The July reading was -1.4%. The high level of exports is likely down to a large amount of personal protective equipment being sold to various governments around the world. The decline in imports points to continued weak internal demand.

He said, it was reported the Trump administration is considering imposing export restrictions on the Hong Kong-listed company, Semiconductor Manufacturing International Corporation. Stocks in Asia are mixed, and European indices are tipped to rebound.

Equity markets in Europe are likely to be quiet today as the stock markets in the US and Canada will remain closed for public holidays, Madden said.

Brexit talks were set to be in focus, with discussions between both sides due to resume amid reports the UK government is planning new legislation that would override a key part of last year’s EU withdrawal agreement.

In corporate news, Associated British Foods said Primark’s annual profit would at least be at the top of guidance after strong trading at the clothes chain in the fourth quarter.

Primark’s operating profit excluding exceptional charges for the year to 12 September will be at the top end or better of the stated £300m-£350m range compared with £913m a year earlier. ABF said trading at Primark and its food businesses exceeded expectations in the fourth quarter.

Veterinary drugs firm Dechra Pharmaceuticals reported higher full year profits and raised its dividend as it made an “encouraging” start to the new fiscal year.

The company said pre-tax profits rose 47.1% to £47.3m as revenue rose 7% to £502m. The total dividend was increased by 8.5% to 34.29p a share.


The articles are for information purposes only and Precise Investors shall not be held responsible for any errors, omissions or inaccuracies within it. Any rules or regulations mentioned within the website are those relevant at the time of publication and may not be the most up-to-date.

Precise Investors does not endorse any of the products or services that appear on it or are linked to it and are not liable for any action that you may take as a result of the content of this website, or losses or damage you may incur doing so.

There is no obligation to purchase anything but, if you decide to do so, you are strongly advised to consult a professional adviser before making any investment decisions.

Please remember that investments of any type may rise or fall and past performance does not guarantee future performance in respect of income or capital growth; you may not get back the amount you invested.

Leave a Reply